# **Membranous Nephropathy**
## **OverView**
## **Pathophysiology**
## **Clinical Presentation**
## **Drugs and Diseases Associated with Membranous**
## **Deffinitions of Treatment Response**
## **Treatment**
## **Sources**
* [KDIGO GN Guidlines](https://kdigo.org/guidelines/gd/)
* [Serology based approach](https://pubmed.ncbi.nlm.nih.gov/27777266/)
* [SGLT2 in primary and secondary glomerulonephritis](https://pubmed.ncbi.nlm.nih.gov/37550217/)
* [Rituximab for Severe Membranous Nephropathy](https://pubmed.ncbi.nlm.nih.gov/27352623/)
* [Rituximab or Cyclosporine in Treatment of Membranous Nephropathy](https://pubmed.ncbi.nlm.nih.gov/31269364/)
* [Alternating treatment with corticosteroids and cyclophosphamide superior to tx with tacrolimus and rituximab](https://pubmed.ncbi.nlm.nih.gov/33166580/)
* [Comparison of OBinutuzumab and Rituximab for Treating Primary MN](https://pubmed.ncbi.nlm.nih.gov/39207845/)
* [Combination Rituximab, and low dose cyclophosphamide and prednisone for Primary Membrandous](https://pubmed.ncbi.nlm.nih.gov/34174365/)
